ARCA Biopharma Inc (ABIO): ARCA biopharma and Oruka Therapeutics An...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	105
Posts	16312
Boards Moderated	0
Alias Born	06/24/2014

Awl416

Re: None

Wednesday, 04/03/2024 8:06:14 AM

Wednesday, April 03, 2024 8:06:14 AM

ARCA biopharma and Oruka Therapeutics Announce Merger Agreement

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ABIO News

ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 04/25/2024 08:15:00 PM
Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm • PR Newswire (US) • 04/05/2024 05:09:00 PM
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement • GlobeNewswire Inc. • 04/03/2024 11:30:00 AM
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement • GlobeNewswire Inc. • 04/03/2024 11:30:00 AM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/07/2024 06:08:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:15:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 09:39:21 PM
ARCA biopharma Announces 2023 Financial Results • GlobeNewswire Inc. • 02/01/2024 09:35:07 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/01/2024 09:15:34 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 11:39:46 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:37 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:36 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:24 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:19 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:25:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 09:15:13 PM
Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 12/19/2023 09:25:05 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/19/2023 09:20:02 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/19/2023 09:15:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 09:36:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 08:35:08 PM
ARCA biopharma Announces Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 10/18/2023 08:25:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/18/2023 08:15:25 PM

More ABIO News

InvestorsHub NewsWire

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM

Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM

Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover